Aerie Pharmaceuticals (AERI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -74,810 | -183,101 | -199,581 | -232,569 | -145,105 |
| Depreciation Amortization | 37,500 | 34,158 | 18,114 | 4,088 | 1,725 |
| Accounts receivable | -12,806 | -17,668 | -35,639 | -2,715 | 0 |
| Accounts payable and accrued liabilities | 21,580 | 22,536 | 28,766 | 26,583 | 925 |
| Other Working Capital | -92,562 | 44,890 | -23,956 | 13,388 | -1,314 |
| Other Operating Activity | 21,944 | 34,495 | 61,866 | 38,649 | 50,556 |
| Operating Cash Flow | $-99,154 | $-64,690 | $-150,430 | $-152,576 | $-93,213 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,291 | -3,100 | -9,958 | -31,313 | -15,970 |
| Purchase Of Investment | -132,361 | -116,591 | -165,454 | -56,195 | -104,490 |
| Sale Of Investment | 117,451 | 192,870 | 0 | 108,297 | 88,153 |
| Purchase Sale Intangibles | 0 | 0 | -7,835 | 0 | -10,500 |
| Other Investing Activity | 0 | 0 | -7,835 | 0 | -10,500 |
| Investing Cash Flow | $-18,201 | $73,179 | $-183,247 | $20,789 | $-42,807 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 8,274 | 308,349 | N/A | 0 |
| Debt Repayment | N/A | -8,274 | N/A | N/A | N/A |
| Common Stock Issued | 2,972 | -859 | 1,445 | 139,602 | 135,644 |
| Other Financing Activity | 0 | 0 | -34,995 | -2,566 | 0 |
| Financing Cash Flow | $2,972 | $-859 | $274,799 | $137,036 | $135,644 |
| Beginning Cash Position | 151,570 | 143,940 | 202,818 | 197,569 | 197,945 |
| End Cash Position | 37,187 | 151,570 | 143,940 | 202,818 | 197,569 |
| Net Cash Flow | $-114,383 | $7,630 | $-58,878 | $5,249 | $-376 |
| Free Cash Flow | |||||
| Operating Cash Flow | -99,154 | -64,690 | -150,430 | -152,576 | -93,213 |
| Capital Expenditure | -3,291 | -3,100 | -9,958 | -31,313 | -15,970 |
| Free Cash Flow | -102,445 | -67,790 | -160,388 | -183,889 | -109,183 |